(Q48694002)

14 February 2018

title

Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure (English)

1 reference

14 February 2018

main subject

heart failure

0 references

congestive heart failure

1 reference

Koglin J

1

1 reference

14 February 2018

Pehlivanli S

2

1 reference

14 February 2018

Schwaiblmair M

3

1 reference

14 February 2018

Vogeser M

4

1 reference

14 February 2018

Cremer P

5

1 reference

14 February 2018

vonScheidt W

6

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 December 2001

1 reference

14 February 2018

Journal of the American College of Cardiology

published in

1 reference

14 February 2018

volume

38

1 reference

14 February 2018

issue

7

1 reference

14 February 2018

page(s)

1934-1941

1 reference

14 February 2018

Prognosis of congestive heart failure and predictors of mortality

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Predictors of prognosis in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Prediction of outcome in late-stage cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Biochemical detection of left-ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Natriuretic peptide system in human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Lung function and cardiopulmonary exercise performance after heart transplantation: influence of cardiac allograft vasculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Hormones and hemodynamics in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

1 reference

7 January 2021

Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Plasma brain natriuretic peptide in assessment of acute dyspnoea

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

10.1016/S0735-1097(01)01672-2

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018